Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Recall of Two (2) Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity | FDA

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Recall of Two (2) Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity | FDA: East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg, to the consumer level from the US market due to presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N

Comments

Post a Comment

Popular posts from this blog

Reduced public health measures contributed to deadly COVID-19 surge in the Americas, PAHO Director says - PAHO/WHO | Pan American Health Organization

Reduced public health measures contributed to deadly COVID-19 surge in the Americas, PAHO Director says - PAHO/WHO | Pan American Health Organization : Deaths rose to 202 people per hour in the Region, despite overall decline in cases. Washington D.C. February 16, 2022 (PAHO) – Complacency around mask wearing, travel, and indoor gatherings created a perfect opportunity for the new Omicron variant to spread rapidly throughout the region and increase deaths, alerted PAHO Director, Carissa F. Etienne, with many places remaining “just as they were before.”
Read more